GenSight Biologics is based in Paris, France. It has raised $264M in total funding. Backed by Versant Ventures, Abingworth, Index Ventures.
GenSight Biologics funding overview
GenSight Biologics is based in Paris, France. GenSight Biologics has raised $264M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for GenSight Biologics runs through 2025; nothing later has been disclosed. Investors on record include Versant Ventures, Abingworth, Index Ventures. 3 distinct backers are named across the disclosed rounds.
GenSight Biologics at a glance
Total raised
$264M
Latest round date
September 2025
Headquarters
Paris, France
Notable investors
Versant Ventures, Abingworth, Index Ventures
Frequently asked about GenSight Biologics funding
How much has GenSight Biologics raised?
GenSight Biologics has raised $264M in total disclosed funding across the rounds on record.
Who has invested in GenSight Biologics?
Versant Ventures, Abingworth, Index Ventures are named among the investors backing GenSight Biologics.
What was the latest GenSight Biologics funding round?
No round stage has been disclosed for GenSight Biologics.
Where is GenSight Biologics based?
GenSight Biologics is based in Paris, France.
When did GenSight Biologics last raise?
The last disclosed GenSight Biologics round closed in September 2025.
Totals shown for GenSight Biologics aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.
